Resultados de la búsqueda 411-420 of 9424 for monoclonal antibody

  1. Oncología (médica) - Ensayos clínicos

    Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...

  4. Oncología (médica) - Ensayos clínicos

    Monoclonal antibodies, such as rituximab, may block cancer growth in different ways by targeting certain cells. Romidepsin and lenalidomide may stop the ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Denosumab is a monoclonal antibody that is used to treat bone loss in order ... Immunotherapy with monoclonal antibodies, such as atezolizumab, may ...

  7. Ensayos clínicos - Hematología

    Monoclonal antibodies, such as rituximab, may block cancer growth in different ways by targeting certain cells. Romidepsin and lenalidomide may stop the growth ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ...

  9. Oncología (médica) - Ensayos clínicos

    UP-NEXT is a double-blind, randomized, placebo controlled study of the antibody ... Immunotherapy with monoclonal antibodies, such as durvalumab, may help the ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    A Study of AZD2936 Anti-TIGIT/Anti-PD-1 Bispecific Antibody in Participants With Advanced or Metastatic NSCLC ... monoclonal antibody, and compare them with ...